167 related articles for article (PubMed ID: 9699922)
1. L-ornithine-L-aspartate in experimental portal-systemic encephalopathy: therapeutic efficacy and mechanism of action.
Rose C; Michalak A; Pannunzio P; Therrien G; Quack G; Kircheis G; Butterworth RF
Metab Brain Dis; 1998 Jun; 13(2):147-57. PubMed ID: 9699922
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of L-carnitine in ammonia-precipitated encephalopathy in the portacaval shunted rat.
Therrien G; Rose C; Butterworth J; Butterworth RF
Hepatology; 1997 Mar; 25(3):551-6. PubMed ID: 9049197
[TBL] [Abstract][Full Text] [Related]
3. L-ornithine vs. L-ornithine-L-aspartate as a treatment for hyperammonemia-induced encephalopathy in rats.
Vogels BA; Karlsen OT; Mass MA; Boveé WM; Chamuleau RA
J Hepatol; 1997 Jan; 26(1):174-82. PubMed ID: 9148009
[TBL] [Abstract][Full Text] [Related]
4. L-ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure.
Rose C; Michalak A; Rao KV; Quack G; Kircheis G; Butterworth RF
Hepatology; 1999 Sep; 30(3):636-40. PubMed ID: 10462368
[TBL] [Abstract][Full Text] [Related]
5. Selective alterations of extracellular brain amino acids in relation to function in experimental portal-systemic encephalopathy: results of an in vivo microdialysis study.
Rao VL; Audet RM; Butterworth RF
J Neurochem; 1995 Sep; 65(3):1221-8. PubMed ID: 7643101
[TBL] [Abstract][Full Text] [Related]
6. The effects of ammonia and portal-systemic shunting on brain metabolism, neurotransmission and intracranial hypertension in hyperammonaemia-induced encephalopathy.
Vogels BA; van Steynen B; Maas MA; Jörning GG; Chamuleau RA
J Hepatol; 1997 Feb; 26(2):387-95. PubMed ID: 9059962
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
[TBL] [Abstract][Full Text] [Related]
8. Treatment of cirrhotic rats with L-ornithine-L-aspartate enhances urea synthesis and lowers serum ammonia levels.
Gebhardt R; Beckers G; Gaunitz F; Haupt W; Jonitza D; Klein S; Scheja L
J Pharmacol Exp Ther; 1997 Oct; 283(1):1-6. PubMed ID: 9336301
[TBL] [Abstract][Full Text] [Related]
9. Intestinal glutamine and ammonia metabolism during chronic hyperammonaemia induced by liver insufficiency.
Dejong CH; Deutz NE; Soeters PB
Gut; 1993 Aug; 34(8):1112-9. PubMed ID: 7909784
[TBL] [Abstract][Full Text] [Related]
10. Mild hypothermia delays the onset of coma and prevents brain edema and extracellular brain glutamate accumulation in rats with acute liver failure.
Rose C; Michalak A; Pannunzio M; Chatauret N; Rambaldi A; Butterworth RF
Hepatology; 2000 Apr; 31(4):872-7. PubMed ID: 10733542
[TBL] [Abstract][Full Text] [Related]
11. Increased cerebrospinal fluid lactate reflects deterioration of neurological status in experimental portal-systemic encephalopathy.
Therrien G; Giguère JF; Butterworth RF
Metab Brain Dis; 1991 Dec; 6(4):225-31. PubMed ID: 1812395
[TBL] [Abstract][Full Text] [Related]
12. Precipitation of overt encephalopathy in the portacaval shunted rat: towards the development of an adequate model of chronic portal systemic encephalopathy.
Mullen KD; Roessle M; Jones DB; Grun M; Jones EA
Eur J Gastroenterol Hepatol; 1997 Mar; 9(3):293-8. PubMed ID: 9096433
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and Pharmacodynamic Properties of L-Ornithine L-Aspartate (LOLA) in Hepatic Encephalopathy.
Kircheis G; Lüth S
Drugs; 2019 Feb; 79(Suppl 1):23-29. PubMed ID: 30706424
[TBL] [Abstract][Full Text] [Related]
14. Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study.
Stauch S; Kircheis G; Adler G; Beckh K; Ditschuneit H; Görtelmeyer R; Hendricks R; Heuser A; Karoff C; Malfertheiner P; Mayer D; Rösch W; Steffens J
J Hepatol; 1998 May; 28(5):856-64. PubMed ID: 9625322
[TBL] [Abstract][Full Text] [Related]
15. Proton MR spectroscopy of neurometabolites in hepatic encephalopathy during L-ornithine-L-aspartate treatment--results of a pilot study.
Delcker A; Turowski B; Mihm U; Raab P; Rusch O; Pilatus U; Zeuzem S; Zanella FE
Metab Brain Dis; 2002 Jun; 17(2):103-11. PubMed ID: 12083335
[TBL] [Abstract][Full Text] [Related]
16. Effects of ornithine aminotransferase inactivation by 5-fluoromethylornithine in rats following portacaval anastomosis.
Therrien G; Sarhan S; Knödgen B; Butterworth RF; Seiler N
Metab Brain Dis; 1994 Sep; 9(3):211-24. PubMed ID: 7838064
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy.
Blanco Vela CI; Poo Ramírez JL
Ann Hepatol; 2011 Jun; 10 Suppl 2():S55-9. PubMed ID: 22228883
[TBL] [Abstract][Full Text] [Related]
18. [The effect of lactitol (NS-4) on the concentrations of ammonia and amino acids in blood and cerebrospinal fluid in Eck fistula (portacaval-shunted) dogs].
Watanabe M; Ozaki T; Hirata Y; Yoshikuni Y; Kimura K; Suzuki K; Sato S
Nihon Yakurigaku Zasshi; 1995 May; 105(5):389-402. PubMed ID: 7628787
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of L-ornithine-L-aspartate in the management of hepatic encephalopathy.
Kircheis G; Wettstein M; Dahl Sv; Häussinger D
Metab Brain Dis; 2002 Dec; 17(4):453-62. PubMed ID: 12602521
[TBL] [Abstract][Full Text] [Related]
20. Glutamine, myo-inositol, and organic brain osmolytes after portocaval anastomosis in the rat: implications for ammonia-induced brain edema.
Cordoba J; Gottstein J; Blei AT
Hepatology; 1996 Oct; 24(4):919-23. PubMed ID: 8855198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
